Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Generating income for early retirement is crucial. Discover various methods to boost your funds and ensure a stable financial future.
20,985 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
Fraudsters used Nigel Farage cameo videos to push unregulated crypto tokens, sparking rapid price spikes and steep de...
The post-IPO market is buzzing about Swarmer, but excitement can blur judgment. Here are three practical realities ev...
OpenAI has discontinued its Sora video generator, a move that highlights the risks and costs of turning AI prototypes...
A sub-$1 pre-IPO company behind a headset-first work platform says 1.5m+ people spend their work week in headsets. It...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
Morgan Stanley warns a disruption through the Strait of Hormuz could lift Brent to as high as $150 a barrel by summer...
Meta forced a mass internal transfer of 1,000 engineers into a new AI unit, signaling a dramatic push into generative...
Brody Gapp LLP unveils a mortgage AI governance audit practice and plans a Q3 2026 release of a comprehensive governa...
Two key on-chain signals—Coinbase Premium and Exchange Netflows—may lead Bitcoin moves as Warsh takes the helm and li...